Kuros Biosciences (KURN.SW) traded down -0.29 % during a 24 hours period ending at 06:24 PM Central Europe on Monday 26th. One Kuros Biosciences stock can currently be bought for about CHF 21 on popular exchanges. Current supply of Kuros Biosciences stocks is 39.8 mn. Kuros Biosciences has a current market capitalization of CHF 807.1 mn and approximately CHF 4.6 mn worth of Kuros Biosciences was traded on exchanges in the last 24 hours. Since last month end, Kuros Biosciences has traded 18.16 % up. Simple moving average of last 200 days is at CHF 21.9. The highest price of past 52 weeks was recorded at CHF 32.48 on 11/28/2025. 52 weeks low was at CHF 16.46 on 09/18/2026.
Here is how related stocks have performed in the past 24 hours:
Basilea Pharmaceutica (BSLN.SW) traded down -1.15 % and now trades at CHF 68.9. Current market capitalisation for Basilea Pharmaceutica is CHF 850.8 mn. Current price/earnings ratio for Basilea Pharmaceutica is 17.11.
Docmorris (DOCM.SW) traded down -2.35 % and now trades at CHF 14.87. Docmorris has a market capitalisation of CHF 775 mn.
Plazza (PLAN.SW) traded flat 0 % and now trades at CHF 426. Current market capitalisation for Plazza is CHF 879.8 mn. Current price/earnings ratio for Plazza is 11.32.
Infracore (INFRAC.SW) traded down -0.58 % and now trades at CHF 51. Current market capitalisation for Infracore is CHF 780.1 mn.
About Kuros Biosciences
Kuros Biosciences AG, a Swiss company headquartered in Schlieren, specializes in developing products for tissue repair and regeneration with a primary focus on orthobiologics. The company offers products to fill bony defects of the human skeletal system and stimulate bone formation at the site of injury. Kuros Biosciences operates in both the United States and Europe. You can find more information about their products and services on their website, www.kuros.ch , and they are listed on the SIX Swiss Exchange.
